March 12, 2026 10:19 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Supreme Court allows first-ever passive euthanasia for 32-year-old man in coma for 13 years | As Iran-US war disrupts global gas supply, India issues guidelines to manage shortages | LPG crisis hits metros: Commercial cylinder shortage triggers panic as govt prioritises domestic supply | Iran war disrupts LPG supplies, restaurants in major Indian cities edge towards shutdown | ‘How dare you question judicial officers?’: SC raps Bengal SIR pleas, orders appellate tribunals for voter list appeals | 'Book withdrawn': NCERT apologises for controversial judiciary chapter after Supreme Court ban | Indian stock market surges as Brent crude dips below $100 after Trump’s Iran remarks | Australia grants asylum to five Iranian women footballers after anthem protest; Albanese says ‘they are safe here’ | Trump administration labels Afghanistan ‘state sponsor of wrongful detention’ | Trump threatens Iran with ‘20 times harder’ strike if oil flow through Strait of Hormuz is disrupted
Monkeypox
CDC

Centre invites bid to develop diagnostic kits, vaccines against monkeypox

| @indiablooms | Jul 28, 2022, at 05:55 am

New Delhi/UNI: The Indian Council of Medical Research (ICMR) on Wednesday announced that it has invited Expression of Interest (EoI) from pharmaceutical manufacturers to develop diagnostic kits and vaccines for the monkeypox virus.

The EoI has been invited by experienced vaccine manufacturers and in-vitro diagnostic (IVD) kit manufacturers for joint collaboration in developing vaccine candidates against monkeypox. The last date for submission of EOI is August 10.

"ICMR has invited an Expression of Interest (EoI) proposing to handover the isolated virus strain of Monkeypox to interested Indian vaccine and In-Vitro Diagnostic (IVD) industry partners for the development of indigenous vaccine & diagnostic kits," the announcement by the apex medical research body read.

The ICMR said that it would provide technical support to the industry partners in the development of IVD kits and vaccines.

The development has come after the National Institute of Virology successfully isolated the monkeypox virus from the clinical specimen of an infected patient paving the way for the development of diagnostic kits and vaccines against the disease.

Senior scientists at the central virus research institute said the virus isolation enhances India's capacity to do research and development in many other directions that will help in forming diagnosis and treatment protocols for the disease.

"The virus can now be used for clinical observations by testing on laboratory animals to assess its impact on the human body. Besides, it will help in developing diagnostic tools to confirm its presence in suspected and infected individuals. Also, it could be used to develop an effective vaccine. There are several possibilities and work on them will be started after getting a go-ahead from the authorities," a senior scientist from NIV told UNI.

Monkeypox, declared a public health emergency of international concern, has spread over 75 nations with more than 17,000 confirmed cases. India has reported four cases of Monkeypox so far.

Kerala was the first state to confirm a Monkeypox case, the number later increased to three in the same state. The fourth confirmed case was reported in Delhi in a 34-year-old man with no recent history of international travel.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.